Terry M. Therneau

85.4k citations

403 papers · 58.1k indexed · 22 hit papers · h-index 107

Epidemiology top 0.02%
Hepatology top 0.02%
Molecular Biology top 0.2%
Surgery top 0.05%
Hematology top 0.05%

Co-authors: Patricia M. Grambsch Peter McCullagh J. A. Nelder W. Ray Kim Robert A. Kyle S. Vincent Rajkumar Dirk R. Larson Russell H. Wiesner
Topics: Liver Disease Diagnosis and Treatment (82 papers)Multiple Myeloma Research and Treatments (48 papers)Liver Disease and Transplantation (44 papers)
Cited by: Hepatology Hematology Epidemiology
Journals: New England Journal of Medicine The Lancet JAMA
Partner nations: United States Belarus South Korea

In The Last Decade

Terry M. Therneau

396 papers receiving 56.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modeling Survival Data: Extending the Cox Model

2000 6.2k citations Terry M. Therneau et al. profile →
Proportional hazards tests and diagnostics based on weighted residuals

1994 4.2k citations Terry M. Therneau et al. profile →
Generalized Linear Models (2nd ed.).

1993 4.2k citations Terry M. Therneau et al. profile →
A Model to Predict Survival in Patients With End–Stage Liver Disease

2001 3.7k citations Walter K. Kremers, Terry M. Therneau et al. Hepatology profile →
The NAFLD fibrosis score

2007 2.3k citations Terry M. Therneau et al. Hepatology profile →
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

2003 1.6k citations Robert A. Kyle, Morie A. Gertz et al. profile →
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List

2008 1.0k citations W. Ray Kim, Walter K. Kremers et al. profile →
A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance

2002 969 citations Robert A. Kyle, Terry M. Therneau et al. profile →
Prevalence of Monoclonal Gammopathy of Undetermined Significance

2006 899 citations Robert A. Kyle, Terry M. Therneau et al. profile →
Martingale-based residuals for survival models

1990 772 citations Terry M. Therneau et al. profile →
Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis

2004 639 citations Angela Dispenzieri, Morie A. Gertz et al. profile →
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

2012 600 citations Donghee Kim, W. Ray Kim et al. Hepatology profile →
Defining imaging biomarker cut points for brain aging and Alzheimer's disease

2016 583 citations Clifford R. Jack, Heather J. Wiste et al. Alzheimer s & Dementia profile →
Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

2007 580 citations Robert A. Kyle, Terry M. Therneau et al. profile →
Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955–2007

2010 567 citations Cynthia S. Crowson, Terry M. Therneau et al. profile →
Evidence-Based Incorporation of Serum Sodium Concentration Into MELD

2006 561 citations W. Ray Kim, Joanne Benson et al. Gastroenterology profile →
An Introduction to Recursive Partitioning Using the RPART Routines

2015 497 citations Terry M. Therneau, Elizabeth J. Atkinson profile →
Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

2011 407 citations Cynthia S. Crowson, Terry M. Therneau et al. profile →
The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases

2010 402 citations Cynthia S. Crowson, Terry M. Therneau et al. profile →
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance

2018 351 citations Robert A. Kyle, Dirk R. Larson et al. profile →
Recursive Partitioning and Regression Trees

2015 336 citations Terry M. Therneau et al. profile →
Longitudinal tau PET in ageing and Alzheimer’s disease

2018 289 citations Clifford R. Jack, Heather J. Wiste et al. Brain profile →

Peers

Countries citing papers authored by Terry M. Therneau

Since Specialization

Citations

This map shows the geographic impact of Terry M. Therneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry M. Therneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry M. Therneau more than expected).

Fields of papers citing papers by Terry M. Therneau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry M. Therneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry M. Therneau. The network helps show where Terry M. Therneau may publish in the future.

Co-authorship network of co-authors of Terry M. Therneau

This figure shows the co-authorship network connecting the top 25 collaborators of Terry M. Therneau. A scholar is included among the top collaborators of Terry M. Therneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry M. Therneau. Terry M. Therneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Staging Alzheimer’s disease through amyloid and tau PET 2025 ·Brain ·Derek R. Johnson,Heather J. Wiste,Val J. Lowe,Christopher G. Schwarz,David S. Knopman,Prashanthi Vemuri,Kejal Kantarci,Bradley F. Boeve,Jonathan Graff‐Radford,Petrice M. Cogswell,Matthew L. Senjem,Terry M. Therneau,Michael Griswold,(unknown),Ronald Petersen,Clifford R. Jack	0
2	Modeling the temporal evolution of plasma p‐tau in relation to amyloid beta and tau PET 2023 ·Alzheimer s & Dementia ·Petrice M. Cogswell,Emily S. Lundt,Terry M. Therneau,Heather J. Wiste,Jonathan Graff‐Radford,Alicia Algeciras‐Schimnich,Val J. Lowe,Michelle M. Mielke,Christopher G. Schwarz,Matthew L. Senjem,Jeffrey L. Gunter,David S. Knopman,Prashanthi Vemuri,Ronald C. Petersen,Clifford R. Jack	14
3	Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH 2023 ·Hepatology ·Jiahui Li,Xin Lü,Zheng Zhu,(unknown),Taofic Mounajjed,Terry M. Therneau,Sudhakar K. Venkatesh,Yi Sui,Kevin J. Glaser,(unknown),Armando Manduca,Vijay H. Shah,Richard L. Ehman,Alina M. Allen,Meng Yin	13
4	Predicting amyloid PET and tau PET stages with plasma biomarkers 2023 ·Brain ·Clifford R. Jack,Heather J. Wiste,Alicia Algeciras‐Schimnich,Daniel J. Figdore,Christopher G. Schwarz,Val J. Lowe,Vijay K. Ramanan,Prashanthi Vemuri,Michelle M. Mielke,David S. Knopman,Jonathan Graff‐Radford,Bradley F. Boeve,Kejal Kantarci,Petrice M. Cogswell,Matthew L. Senjem,Jeffrey L. Gunter,Terry M. Therneau,Ronald C. Petersen	67
5	CSF phosphorylated tau as an indicator of subsequent tau accumulation 2022 ·Neurobiology of Aging ·Petrice M. Cogswell,Heather J. Wiste,Michelle M. Mielke,Christopher G. Schwarz,Stephen D. Weigand,Val J. Lowe,Terry M. Therneau,David S. Knopman,(unknown),Prashanthi Vemuri,Matthew L. Senjem,Jeffrey L. Gunter,(unknown),Ronald C. Petersen,Clifford R. Jack	4
6	Longitudinal Changes in MR Elastography–based Biomarkers in Obese Patients Treated with Bariatric Surgery 2021 ·Clinical Gastroenterology and Hepatology ·Jiahui Li,Alina M. Allen,Vijay H. Shah,Armando Manduca,Richard L. Ehman,Meng Yin,Terry M. Therneau,Taofic Mounajjed,Kevin J. Glaser,Sudhakar K. Venkatesh	8
7	NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages 2021 ·Annals of Neurology ·Ronald C. Petersen,Heather J. Wiste,Stephen D. Weigand,Julie A. Fields,Yonas E. Geda,Jonathan Graff‐Radford,David S. Knopman,Walter K. Kremers,Val J. Lowe,Mary M. Machulda,Michelle M. Mielke,Nikki H. Stricker,Terry M. Therneau,Prashanthi Vemuri,Clifford R. Jack	42
8	Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis 2021 ·European Radiology ·Jie Chen,Alina M. Allen,Terry M. Therneau,Jun Chen,Jiahui Li,(unknown),Jingbiao Chen,Xin Lü,Zheng Zhu,Sudhakar K. Venkatesh,Bin Song,Richard L. Ehman,Meng Yin	18
9	Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers 2020 ·NeuroImage ·Petrice M. Cogswell,Heather J. Wiste,Matthew L. Senjem,Jeffrey L. Gunter,Stephen D. Weigand,Christopher G. Schwarz,Arvin Arani,Terry M. Therneau,Val J. Lowe,David S. Knopman,Hugo Botha,Jonathan Graff‐Radford,David T. Jones,Kejal Kantarci,Prashanthi Vemuri,Bradley F. Boeve,Michelle M. Mielke,Ronald C. Petersen,Clifford R. Jack	75
10	Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma 2020 ·Hepatology ·Sravanthi Lavu,Terry M. Therneau,William S. Harmsen,Kristin C. Mara,Nicha Wongjarupong,(unknown),Hamdi A. Ali,Samuel O. Antwi,Nasra H. Giama,Katsuyuki Miyabe,Lewis R. Roberts	20
11	Multiparametric Magnetic Resonance Elastography Improves the Detection of NASH Regression Following Bariatric Surgery 2019 ·Hepatology Communications ·Alina M. Allen,Vijay H. Shah,Terry M. Therneau,Sudhakar K. Venkatesh,Taofic Mounajjed,Joseph J. Larson,Kristin C. Mara,Todd A. Kellogg,Michael L. Kendrick,Travis J. McKenzie,Suzanne Greiner,Jiahui Li,Kevin J. Glaser,Michael Wells,(unknown),Richard L. Ehman,Meng Yin	32
12	The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes 2019 ·Brain ·Clifford R. Jack,Heather J. Wiste,Hugo Botha,Stephen D. Weigand,Terry M. Therneau,David S. Knopman,Jonathan Graff‐Radford,David T. Jones,Tanis J. Ferman,Bradley F. Boeve,Kejal Kantarci,Val J. Lowe,Prashanthi Vemuri,Michelle M. Mielke,Julie A. Fields,Mary M. Machulda,Christopher G. Schwarz,Matthew L. Senjem,Jeffrey L. Gunter,Ronald C. Petersen	126
13	The rationale, design, and methods of a randomized, controlled trial to evaluate the effectiveness of collaborative telecare in preserving function among patients with late stage cancer and hematologic conditions 2017 ·Contemporary Clinical Trials ·Andrea Cheville,Timothy J. Moynihan,Jeffrey R. Basford,John A. Nyman,(unknown),(unknown),Terry M. Therneau,(unknown),Kurt Kroenke	18
14	Assessing calibration of prognostic risk scores 2013 ·Statistical Methods in Medical Research ·Cynthia S. Crowson,Elizabeth J. Atkinson,Terry M. Therneau	170
15	Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United Statesbreakdown → 2012 ·Hepatology ·Donghee Kim,W. Ray Kim,Hwa Jung Kim,Terry M. Therneau	600
16	Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance 2009 ·Blood ·Celine M. Vachon,Robert A. Kyle,Terry M. Therneau,(unknown),Dirk R. Larson,Colin Colby,(unknown),Angela Dispenzieri,Shaji Kumar,Jerry A. Katzmann,S. Vincent Rajkumar	87
17	Fracture Risk in Type 2 Diabetes: Update of a Population-Based Study 2008 ·Journal of Bone and Mineral Research ·L. Joseph Melton,Cynthia L. Leibson,Sara J. Achenbach,Terry M. Therneau,Sundeep Khosla	314
18	Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma 2007 ·Blood ·Angela Dispenzieri,Robert A. Kyle,Jerry A. Katzmann,Terry M. Therneau,Dirk R. Larson,Joanne Benson,Raynell Clark,L. Joseph Melton,Morie A. Gertz,Shaji Kumar,Rafaël Fonseca,Diane F. Jelinek,S. Vincent Rajkumar	285
19	A Prospective Study of CD38/45 Flow Cytometry and Immunofluorescence Microscopy to Detect Blood Plasma Cells in Patients with Plasma Cell Proliferative Disorders 2000 ·Leukemia & lymphoma ·Thomas E. Witzig,(unknown),Terry M. Therneau,Philip R. Greipp	5
20	Epidemiology and natural history of primary biliary cirrhosis in a U.S. community 2000 ·Gastroenterology ·W. Ray Kim,Keith D. Lindor,G. Richard Locke,Terry M. Therneau,Henry A. Homburger,Kenneth P. Batts,Barbara P. Yawn,Janice L. Petz,L. Joseph Melton,E. Rolland Dickson	257

About Terry M. Therneau

Terry M. Therneau is a scholar working on Hepatology, Hematology and Genetics, having authored 403 papers that have together received 58.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (82 papers), Multiple Myeloma Research and Treatments (48 papers) and Liver Disease and Transplantation (44 papers). The work is most often cited by research in Hepatology (12.7k citations), Hematology (7.8k citations) and Epidemiology (15.6k citations). Terry M. Therneau has collaborated with scholars based in United States, Belarus and South Korea. Frequent co-authors include Patricia M. Grambsch, Peter McCullagh, J. A. Nelder, W. Ray Kim, Robert A. Kyle, S. Vincent Rajkumar, Dirk R. Larson, Russell H. Wiesner, Patrick S. Kamath and Angela Dispenzieri. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact